Diverse alterations associated with resistance to KRAS(G12C) inhibition
Yulei Zhao, Yonina R. Murciano‐Goroff, Jenny Y. Xue, Agnes Ang, Jessica Lucas, Trang T. Mai, Arnaud Da Cruz Paula, Anne Y. Saiki, Deanna Mohn, Pragathi Achanta, Ann Elizabeth Sisk, Kanika Arora, Rohan S. Roy, Dong-Sung Kim, Chuanchuan Li, Lee P. Lim, Mark Li, Amber Bahr, Brian Houck‐Loomis, Elisa de Stanchina, Jorge S. Reis-Filho, Britta Weigelt, Michael F. Berger, Gregory J. Riely, Kathryn C. Arbour, J. Russell Lipford, Bob T. Li, Piro Lito
Topics & Concepts
KRASNeuroblastoma RAS viral oncogene homologCancer researchMAPK/ERK pathwayMEK inhibitorMutationBiologyMedicineGeneticsGeneKinaseProtein Kinase Regulation and GTPase SignalingPI3K/AKT/mTOR signaling in cancerLung Cancer Treatments and Mutations